Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AstraZeneca Donates $27.6 Million Worth Of Iressa To China

This article was originally published in PharmAsia News

Executive Summary

AstraZeneca is donating $27.6 million worth of its Iressa (gefitinib) cancer drug to a Chinese foundation to distribute to needy cancer patients. The China Charity Federation already has distributed $10 million worth of the tablets to patients with advanced non-small cell lung cancer and plans to distribute the rest this year. A vice president of the Anglo-Swedish AstraZeneca announced the gift at a ceremony in Beijing. The drug is available to those who have had at least one chemotherapy treatment and have used Iressa for at least six months before applying for the free tablets. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066694

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel